Offer - Urjas Oil for just ₹ 1
Nebimek LN is an allopathic medicine The correct dosage of Nebimek LN depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Nebimek LN is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Nebimek LN safe for pregnant women?
Nebimek LN has many dangerous side effects in pregnant women. If you are pregnant, do not consume Nebimek LN without medical advice.
Is the use of Nebimek LN safe during breastfeeding?
Taking Nebimek LN may lead to serious side effects if you are breastfeeding. Nebimek LN should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Nebimek LN on the Kidneys?
Nebimek LN may have mild side effects on the kidneys.
What is the effect of Nebimek LN on the Liver?
Very few cases of side effects of Nebimek LN on the liver have been reported.
What is the effect of Nebimek LN on the Heart?
Very few cases of side effects of Nebimek LN on the heart have been reported.
Nebimek LN should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nebimek LN unless your doctor advises you to do so -
Is this Nebimek LN habit forming or addictive?
No, you will not get addicted to Nebimek LN.
Interaction between Food and Nebimek LN
Eating certain foods may increase the time it takes Nebimek LN to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nebimek LN
Taking Nebimek LN with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
